Publisher Correction: 10.1038/s41401-020-0400-z,10.1038/s41401-020-0414-6,10.1038/s41401-020-0372-z

Published Erratum

Springer Springer Singapore. Acta Pharmacol Sin. 2021 May.

. 2021 May;42(5):844.

doi: 10.1038/s41401-020-0464-9.

No abstract available

Erratum for

Advanced biomaterials for cancer immunotherapy.
Yang F, Shi K, Jia YP, Hao Y, Peng JR, Qian ZY. Yang F, et al. Acta Pharmacol Sin. 2020 Jul;41(7):911-927. doi: 10.1038/s41401-020-0372-z. Epub 2020 Mar 2. Acta Pharmacol Sin. 2020. PMID: 32123302 Free PMC article. Review.
Engineering nanomedicines through boosting immunogenic cell death for improved cancer immunotherapy.
Gao J, Wang WQ, Pei Q, Lord MS, Yu HJ. Gao J, et al. Acta Pharmacol Sin. 2020 Jul;41(7):986-994. doi: 10.1038/s41401-020-0400-z. Epub 2020 Apr 21. Acta Pharmacol Sin. 2020. PMID: 32317755 Free PMC article. Review.
Nanomedicines based on nanoscale metal-organic frameworks for cancer immunotherapy.
Zhong XF, Sun X. Zhong XF, et al. Acta Pharmacol Sin. 2020 Jul;41(7):928-935. doi: 10.1038/s41401-020-0414-6. Epub 2020 Apr 30. Acta Pharmacol Sin. 2020. PMID: 32355277 Free PMC article. Review.